NCT01928394 2024-12-27A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid TumorsBristol-Myers SquibbPhase 1/2 Completed1,163 enrolled 33 charts 1 FDA
NCT02784171 2024-12-10Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaCanadian Cancer Trials GroupPhase 2/3 Completed520 enrolled 16 charts 1 FDA
NCT02454972 2023-03-02Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid TumorsPharmaMarPhase 2 Completed345 enrolled 34 charts 2 FDA